186 related articles for article (PubMed ID: 23616407)
1. Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs.
Huang X; Li Y; Fu Y; Ji Y; Lian K; Zheng H; Wei J; Cai X; Zhu Q
Clin Vaccine Immunol; 2013 Jun; 20(6):912-9. PubMed ID: 23616407
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.
Frandoloso R; Martínez S; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Martínez-Fernández B; Gutiérrez-Martín CB
Clin Vaccine Immunol; 2011 Jan; 18(1):50-8. PubMed ID: 20926701
[TBL] [Abstract][Full Text] [Related]
3. New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis.
Barasuol BM; Guizzo JA; Fegan JE; Martínez-Martínez S; Rodríguez-Ferri EF; Gutiérrez-Martín CB; Kreutz LC; Schryvers AB; Frandoloso R
Sci Rep; 2017 Sep; 7(1):10377. PubMed ID: 28871190
[TBL] [Abstract][Full Text] [Related]
4. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
Hau SJ; Eberle KC; Brockmeier SL
Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
Hau SJ; Luan SL; Loving CL; Nicholson TL; Wang J; Peters SE; Seilly D; Weinert LA; Langford PR; Rycroft AN; Wren BW; Maskell DJ; Tucker AW; Brockmeier SL;
BMC Vet Res; 2020 May; 16(1):167. PubMed ID: 32460764
[TBL] [Abstract][Full Text] [Related]
6. Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice.
Fu S; Zhang M; Ou J; Liu H; Tan C; Liu J; Chen H; Bei W
Vaccine; 2012 Nov; 30(48):6839-44. PubMed ID: 23000128
[TBL] [Abstract][Full Text] [Related]
7. Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5.
Li M; Song S; Yang D; Li C; Li G
Vaccine; 2015 Mar; 33(14):1695-701. PubMed ID: 25704800
[TBL] [Abstract][Full Text] [Related]
8. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention.
Li M; Li C; Song S; Kang H; Yang D; Li G
Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332
[TBL] [Abstract][Full Text] [Related]
9. Virulence, transmission, and heterologous protection of four isolates of Haemophilus parasuis.
Brockmeier SL; Loving CL; Mullins MA; Register KB; Nicholson TL; Wiseman BS; Baker RB; Kehrli ME
Clin Vaccine Immunol; 2013 Sep; 20(9):1466-72. PubMed ID: 23885030
[TBL] [Abstract][Full Text] [Related]
10. A vaccine based on a mutant transferrin binding protein B of Haemophilus parasuis induces a strong T-helper 2 response and bacterial clearance after experimental infection.
Martínez-Martínez S; Frandoloso R; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Álvarez-Estrada Á; Gutiérrez-Martín CB
Vet Immunol Immunopathol; 2016 Oct; 179():18-25. PubMed ID: 27590421
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins.
Fu S; Zhang M; Xu J; Ou J; Wang Y; Liu H; Liu J; Chen H; Bei W
Vaccine; 2013 Jan; 31(2):347-53. PubMed ID: 23149270
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a recombinant transferrin-binding protein A (TbpA) fragment from Haemophilus parasuis serovar 5.
Martínez S; Frandoloso R; Rodríguez-Ferri EF; González-Zorn B; Gutiérrez-Martín CB
FEMS Microbiol Lett; 2010 Jun; 307(2):142-50. PubMed ID: 20402790
[TBL] [Abstract][Full Text] [Related]
13. Systemic antibody response in colostrum-deprived pigs experimentally infected with Haemophilus parasuis.
Martín de la Fuente AJ; Rodríguez-Ferri EF; Frandoloso R; Martínez S; Tejerina F; Gutiérrez-Martín CB
Res Vet Sci; 2009 Apr; 86(2):248-53. PubMed ID: 18783805
[TBL] [Abstract][Full Text] [Related]
14. A cross-protection experiment in pigs vaccinated with Haemophilus parasuis serovars 2 and 5 bacterins, and evaluation of a bivalent vaccine under laboratory and field conditions.
Takahashi K; Naga S; Yagihashi T; Ikehata T; Nakano Y; Senna K; Maruyama T; Murofushi J
J Vet Med Sci; 2001 May; 63(5):487-91. PubMed ID: 11411491
[TBL] [Abstract][Full Text] [Related]
15. Soluble expression of OmpA from Haemophilus parasuis in Escherichia coli and its protective effects in the mouse model of infection.
Ahn J; Hong M; Yoo S; Lee E; Won H; Yoon I; Jung JK; Lee H
J Microbiol Biotechnol; 2012 Sep; 22(9):1307-9. PubMed ID: 22814508
[TBL] [Abstract][Full Text] [Related]
16. Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
Zheng X; Yang X; Li X; Qiu GH; Dai A; Huang Q; Huang C; Guo X
Vaccine; 2017 Mar; 35(10):1417-1423. PubMed ID: 28187951
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic characterization of vaccines based on Haemophilus parasuis Nagasaki strain, OmpP2, OmpP5 and OmpD15, in colostrum-deprived pigs experimentally challenged with the same strain.
Álvarez-Estrada Á; Martínez-Martínez S; Martín CG; García-Iglesias MJ; Pérez-Martínez C; Yubero-Delgado S; Guizzo JA; Frandoloso R; Rodríguez-Ferri EF
Res Vet Sci; 2018 Aug; 119():292-301. PubMed ID: 30081339
[TBL] [Abstract][Full Text] [Related]
18. First comparison of adjuvant for trivalent inactivated Haemophilus parasuis serovars 4, 5 and 12 vaccines against Glässer's disease.
Xue Q; Zhao Z; Liu H; Chen K; Xue Y; Wang L
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):153-8. PubMed ID: 26672914
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.
Álvarez-Estrada Á; Gutiérrez-Martín CB; Rodríguez-Ferri EF; Martínez-Martínez S
BMC Vet Res; 2018 Nov; 14(1):326. PubMed ID: 30400794
[TBL] [Abstract][Full Text] [Related]
20. Acute phase protein concentrations in colostrum-deprived pigs immunized with subunit and commercial vaccines against Glässer's disease.
Martínez-Martínez S; Frandoloso R; Gutiérrez-Martín CB; Lampreave F; García-Iglesias MJ; Pérez-Martínez C; Rodríguez-Ferri EF
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):61-7. PubMed ID: 21816489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
